Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Normobaric Hyperoxia in Acute Ischemic Stroke
NCT03620370Completed
- Sponsor
- Capital Medical University
- Start
- Aug 2018
- Primary completion
- Jul 2019
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Randomised, single-blind trial of oxygen in ischemic stroke (2 arms), sponsored by Capital Medical University. Primary endpoint: Cerebral infarct volume. Started Aug 2018; status: completed.
02
Drugs
oxygen
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03620370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03620370.